China Universal Asset Management Co. Ltd. grew its position in shares of AbCellera Biologics Inc. (NASDAQ:ABCL – Free Report) by 352.2% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 33,566 shares of the company’s stock after buying an additional 26,143 shares during the […]
AbCellera Biologics Inc. (NASDAQ:ABCL – Get Free Report) traded down 3.7% on Tuesday . The stock traded as low as $4.40 and last traded at $4.41. 577,359 shares changed hands during trading, a decline of 60% from the average session volume of 1,439,832 shares. The stock had previously closed at $4.58. Analyst Ratings Changes A […]
AbCellera Biologics Inc. (NASDAQ:ABCL – Get Free Report) has been assigned a consensus rating of “Buy” from the nine analysts that are covering the stock, MarketBeat reports. Nine research analysts have rated the stock with a buy recommendation. The average 12-month target price among brokerages that have updated their coverage on the stock in the […]